Sun Pharma Chairman Israel Makov to step down
Advertisement
Sun Pharmaceutical Industries Limited, today announced that its Chairman and member of the Board, Mr Israel Makov, will retire from the company upon the completion of his current term post Sun Pharma's Annual General Meeting on August 29, 2022, after having led the organisation for 10 years.
He was appointed a Board member and the Chairman in 2012. Under his leadership, Sun Pharma transformed from a US$ 1.7 billion organisation focusing on India and the US into the world's fourth largest specialty generic pharmaceutical company operating across 100+ markets with a turnover of over US$ 5 billion.
For more details, check out the full story on the link below:
Israel Makov To Step Down As Sun Pharma Chairman
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.